000 01562 a2200469 4500
005 20250517134201.0
264 0 _c20170407
008 201704s 0 0 eng d
022 _a1651-226X
024 7 _a10.1080/0284186X.2016.1278305
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBoye, Kjetil
245 0 0 _aDenosumab in patients with giant-cell tumor of bone in Norway: results from a nationwide cohort.
_h[electronic resource]
260 _bActa oncologica (Stockholm, Sweden)
_cMar 2017
300 _a479-483 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aBone Density Conservation Agents
_xtherapeutic use
650 0 4 _aBone Neoplasms
_xdrug therapy
650 0 4 _aDatabases, Factual
650 0 4 _aDenosumab
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aGiant Cell Tumor of Bone
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aInjections, Subcutaneous
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNorway
_xepidemiology
650 0 4 _aRetrospective Studies
650 0 4 _aTreatment Outcome
650 0 4 _aYoung Adult
700 1 _aJebsen, Nina Louise
700 1 _aZaikova, Olga
700 1 _aKnobel, Heidi
700 1 _aLøndalen, Ayca M
700 1 _aTrovik, Clement S
700 1 _aMonge, Odd R
700 1 _aHall, Kirsten Sundby
773 0 _tActa oncologica (Stockholm, Sweden)
_gvol. 56
_gno. 3
_gp. 479-483
856 4 0 _uhttps://doi.org/10.1080/0284186X.2016.1278305
_zAvailable from publisher's website
999 _c26802229
_d26802229